Last week, NCPA co-sponsored an event with the American Economic Liberties Project featuring remarks from several Democrats in Congress that focused on corporate concentration and antitrust, specifically regarding the cost of prescriptions drugs, housing, and groceries to consumers.
Sen. Amy Klobuchar (Minn.) opened the event with remarks touting the increased awareness of anticompetitive business practices and how to parlay that momentum into legislative action. Sen. Elizabeth Warren (Mass.) spoke of how attorneys general from dozens of states have engaged in breaking anticompetitive practices through legal action and restricting specific companies from doing business in their states.
Reps. Summer Lee (Penn.) and Chris Deluzio (Penn.) both spoke about the further consolidation of industries that has increased prices and led to product shortages.
At an event earlier in the day, AELP Senior Policy Director Emma Freer spoke about the negative effects of PBMs’ business model, emphasizing the need for material action to drive change.
“Transparency on how PBMs are hurting pharmacists and patients doesn’t help the patients and pharmacies harmed by PBMs. It just gives us more information on how they’re being fleeced,” she said.
NCPA is proud to partner with AELP in their advocacy to prohibit further anticompetitive practices that harm consumers, patients and pharmacies.
